Praj Industries

Praj opens India's first second-generation bio-refinery for renewable fuels

08 May 2017

Praj Industries in pact with IOC to set up three 2G bio-ethanol plants

09 Dec 2016

Praj acquires majority stake in Neela Systems

06 Jan 2012

Qteros and Praj Industries enter into strategic partnership for cellulosic ethanol

05 Jan 2011

Gajanan Nabar is new CEO and MD of Praj Industries

02 Nov 2010

Praj sets up joint venture with Brazil's Jaragua

13 Dec 2007

Praj Industries makes breakthrough in US Mid West ethanol industry

02 Jan 2007

Praj Industries awarded distillery orders by Bajaj Hindustan

16 Oct 2006

Praj Industries, Aker Kvaerner forge a bio-ethanol alliance in Europe

27 Feb 2006

FAQs on ethanol

30 Oct 2004

View details about the software product Informachine News Trackers

Latest articles

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

 Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

 Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

AI startup Reflection signs over $1 billion computing deal with Nebius

 AI startup Reflection signs over $1 billion computing deal with Nebius

Tata Power explores $450 million overseas loan for business operations

 Tata Power explores $450 million overseas loan for business operations

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

 TCS wins technology contract for New York JFK Airport’s $19 billion terminal

South Korean firms unveil $195 billion investment in AI and advanced industries

 South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

 HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

 Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

 AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs